| Product Code: ETC7222567 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Lung Transplant Therapeutics Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Lung Transplant Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 France Lung Transplant Therapeutics Market - Industry Life Cycle |
3.4 France Lung Transplant Therapeutics Market - Porter's Five Forces |
3.5 France Lung Transplant Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 France Lung Transplant Therapeutics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 France Lung Transplant Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 France Lung Transplant Therapeutics Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.9 France Lung Transplant Therapeutics Market Revenues & Volume Share, By Patient Demographics, 2021 & 2031F |
4 France Lung Transplant Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung diseases and respiratory disorders in France |
4.2.2 Technological advancements in lung transplant therapeutics |
4.2.3 Rising healthcare expenditure in France |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of new lung transplant therapeutics |
4.3.2 Limited availability of organ donors for lung transplants in France |
5 France Lung Transplant Therapeutics Market Trends |
6 France Lung Transplant Therapeutics Market, By Types |
6.1 France Lung Transplant Therapeutics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 France Lung Transplant Therapeutics Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 France Lung Transplant Therapeutics Market Revenues & Volume, By Immunosuppressant Drugs, 2021- 2031F |
6.1.4 France Lung Transplant Therapeutics Market Revenues & Volume, By Organ Preservation Products, 2021- 2031F |
6.1.5 France Lung Transplant Therapeutics Market Revenues & Volume, By Tissue Products, 2021- 2031F |
6.2 France Lung Transplant Therapeutics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 France Lung Transplant Therapeutics Market Revenues & Volume, By Chronic Obstructive Pulmonary Diseases (COPD), 2021- 2031F |
6.2.3 France Lung Transplant Therapeutics Market Revenues & Volume, By Pulmonary Fibrosis, 2021- 2031F |
6.2.4 France Lung Transplant Therapeutics Market Revenues & Volume, By Septic Lung Disease, 2021- 2031F |
6.2.5 France Lung Transplant Therapeutics Market Revenues & Volume, By Pulmonary Hypertension, 2021- 2031F |
6.2.6 France Lung Transplant Therapeutics Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.7 France Lung Transplant Therapeutics Market Revenues & Volume, By Interstitial Pulmonary Fibrosis, 2021- 2031F |
6.2.8 France Lung Transplant Therapeutics Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.2.9 France Lung Transplant Therapeutics Market Revenues & Volume, By Sarcoidosis, 2021- 2031F |
6.3 France Lung Transplant Therapeutics Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 France Lung Transplant Therapeutics Market Revenues & Volume, By Cadaveric Lung Transplantation, 2021- 2031F |
6.3.3 France Lung Transplant Therapeutics Market Revenues & Volume, By Living Lung Transplantation, 2021- 2031F |
6.4 France Lung Transplant Therapeutics Market, By Technique |
6.4.1 Overview and Analysis |
6.4.2 France Lung Transplant Therapeutics Market Revenues & Volume, By Single-Lung Transplantation, 2021- 2031F |
6.4.3 France Lung Transplant Therapeutics Market Revenues & Volume, By Bilateral-Lung Transplantation, 2021- 2031F |
6.4.4 France Lung Transplant Therapeutics Market Revenues & Volume, By Heart-Lung Transplantation, 2021- 2031F |
6.4.5 France Lung Transplant Therapeutics Market Revenues & Volume, By Double Lung Transplantation, 2021- 2031F |
6.5 France Lung Transplant Therapeutics Market, By Patient Demographics |
6.5.1 Overview and Analysis |
6.5.2 France Lung Transplant Therapeutics Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5.3 France Lung Transplant Therapeutics Market Revenues & Volume, By Adult, 2021- 2031F |
6.5.4 France Lung Transplant Therapeutics Market Revenues & Volume, By Paediatric, 2021- 2031F |
7 France Lung Transplant Therapeutics Market Import-Export Trade Statistics |
7.1 France Lung Transplant Therapeutics Market Export to Major Countries |
7.2 France Lung Transplant Therapeutics Market Imports from Major Countries |
8 France Lung Transplant Therapeutics Market Key Performance Indicators |
8.1 Patient survival rates post lung transplant |
8.2 Number of lung transplant surgeries performed annually in France |
8.3 Adoption rate of advanced lung transplant therapeutics in hospitals |
9 France Lung Transplant Therapeutics Market - Opportunity Assessment |
9.1 France Lung Transplant Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 France Lung Transplant Therapeutics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 France Lung Transplant Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 France Lung Transplant Therapeutics Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.5 France Lung Transplant Therapeutics Market Opportunity Assessment, By Patient Demographics, 2021 & 2031F |
10 France Lung Transplant Therapeutics Market - Competitive Landscape |
10.1 France Lung Transplant Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 France Lung Transplant Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here